Published July 26, 2023
The newly published report by IMARC Group, titled ”Chronic Obstructive Pulmonary Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the chronic obstructive pulmonary disease market size. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.
Request a Sample Report: www.imarcgroup.com/chronic-obstructive-pulmonary-disease-market/requestsample
What is chronic obstructive pulmonary disease?
Chronic obstructive pulmonary disease
(COPD) stands for a long-term respiratory condition marked by unceasing airflow
restriction, mainly caused by airway inflammation and lung tissue damage.
Symptoms like breathlessness, wheezing, chest discomfort, chronic coughing, and
overproduction of mucus often lead to difficulties in breathing, making
everyday activities strenuous and impairing the quality of life for COPD
patients. It may lead to weight loss, depression, and other systemic
complications. The diagnostic process for COPD usually comprises a review of
medical history, physical check-ups, lung function tests, and imaging
examinations. The patient's history could cover inquiries about symptomatology,
smoking habits, exposure to environmental pollutants, and any familial
incidence of lung disorders. Imaging methods, such as chest X-rays or CT scans,
are employed to pinpoint structural irregularities in the lungs, while blood
tests might be used to rule out other possible causes of the symptoms.
Explore the Full Report with Table of Contents: www.imarcgroup.com/chronic-obstructive-pulmonary-disease-market
What are the key drivers and trends in the chronic obstructive pulmonary disease market?
The chronic obstructive pulmonary
disease market is growing due to the rise in long-term exposure to lung
irritants, including tobacco smoke and air pollutants, which cause inflammation
and narrowing of the airways. The increased presence of risk factors like
exposure to chemical fumes, genetic factors, and respiratory infections such as
pneumonia and bronchitis is also driving the market. The utilization of
medications like bronchodilators, corticosteroids, and phosphodiesterase-4
inhibitors that enhance lung functioning is propelling the market growth. The
market is benefiting from the elevating application of lung volume reduction
surgery (LVRS) for serious COPD patients with significant emphysema, as it
improves lung elasticity and breathing efficiency. The rising use of
non-invasive ventilation techniques that improve oxygenation and breathing in
severe COPD cases without resorting to invasive procedures like intubation or
mechanical ventilation is set to stimulate the chronic obstructive pulmonary
disease market further.
What is included in the report segmentation?
The report covers the following aspects:
Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033
Analysis Covered Across Each Country
Historical, current, and future epidemiology scenario
Historical, current, and future performance of the chronic obstructive pulmonary disease market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the chronic obstructive pulmonary disease market
Reimbursement scenario in the market
In-market and pipeline drugs
Mechanism of Action
Clinical Trial Results
Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
Mechanism of Action
Clinical Trial Results
Ask an Analyst for Report Customization with Table of Contents: www.imarcgroup.com/request?type=report&id=7288&flag=C
How This Report Can Help You:
The report on chronic obstructive pulmonary disease market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the chronic obstructive pulmonary disease market.
The chronic obstructive pulmonary disease market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.
Our report on the chronic obstructive pulmonary disease market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.
Browse Our Latest Healthcare Research Report:
Key Questions Answered in this Report:
How has the chronic obstructive pulmonary disease market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the chronic obstructive pulmonary disease market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the chronic obstructive pulmonary disease market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Email: [email protected]
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800